BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 15998584)

  • 21. The approach to the patient with a parapneumonic effusion.
    Wrightson JM; Davies RJ
    Semin Respir Crit Care Med; 2010 Dec; 31(6):706-15. PubMed ID: 21213202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empyema and effusion: outcome of image-guided small-bore catheter drainage.
    Keeling AN; Leong S; Logan PM; Lee MJ
    Cardiovasc Intervent Radiol; 2008; 31(1):135-41. PubMed ID: 17943347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrapleural streptokinase treatment in children with empyema.
    Aydoğan M; Aydoğan A; Ozcan A; Tugay M; Gokalp AS; Arisoy ES
    Eur J Pediatr; 2008 Jul; 167(7):739-44. PubMed ID: 17710434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors influencing length of hospital stay in patients with bacterial pleural effusion.
    Soriano T; Alegre J; Alemán C; Ruiz E; Vázquez A; Carrasco JL; Segura R; Ferrer A; Fernández de Sevilla T
    Respiration; 2005; 72(6):587-93. PubMed ID: 16106111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of parapneumonic pleural effusions developing during antibiotic treatment for pneumonia.
    Macrea M; Metersky ML
    Conn Med; 2006; 70(6):371-5. PubMed ID: 16869468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrapleural streptokinase for the treatment of childhood empyema.
    Ho MY; Chen HY; Yen YH; Yang YS; Lien SH
    Acta Paediatr Taiwan; 2007; 48(5):251-6. PubMed ID: 18254573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parapneumonic effusion and empyema in children: retrospective review of the duPont experience.
    Padman R; King KA; Iqbal S; Wolfson PJ
    Clin Pediatr (Phila); 2007 Jul; 46(6):518-22. PubMed ID: 17579104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thoracic empyema caused by anaerobes. 78-month retrospective study. Clinical and microbiological aspects].
    Ronchetto F; Pistono PG; Stacchini E; Guasco C
    G Batteriol Virol Immunol; 1992 Jan-1993 Dec; 85(1-12):26-34. PubMed ID: 7498613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics and outcomes of empyema thoracis in 117 patients: a comparative analysis of tuberculous vs. non-tuberculous aetiologies.
    Malhotra P; Aggarwal AN; Agarwal R; Ray P; Gupta D; Jindal SK
    Respir Med; 2007 Mar; 101(3):423-30. PubMed ID: 17045789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of encapsulated pleural effusions in children: a prospective trial.
    Kobr J; Pizingerova K; Sasek L; Fremuth J; Siala K; Racek J
    Pediatr Int; 2010 Jun; 52(3):453-8. PubMed ID: 19919636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The approach to the patient with a parapneumonic effusion.
    Rahman NM; Chapman SJ; Davies RJ
    Clin Chest Med; 2006 Jun; 27(2):253-66. PubMed ID: 16716817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Streptococcus milleri infections of the pleural space: operative management predominates.
    Ripley RT; Cothren CC; Moore EE; Long J; Johnson JL; Haenel JB
    Am J Surg; 2006 Dec; 192(6):817-21. PubMed ID: 17161100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of fibrinolytic agents for draining intrapleural infections.
    Bouros D; Schiza S; Siafakas N
    Semin Respir Infect; 1999 Mar; 14(1):39-47. PubMed ID: 10197396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of thoracic empyema in children.
    Kiliç N; Celebi S; Gürpinar A; Hacimustafaoglu M; Konca Y; Ildirim I; Dogruyol H
    Pediatr Surg Int; 2002 Jan; 18(1):21-3. PubMed ID: 11793057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Stratification in Patients with Complicated Parapneumonic Effusions and Empyema Using the RAPID Score.
    Touray S; Sood RN; Lindstrom D; Holdorf J; Ahmad S; Knox DB; Sosa AF
    Lung; 2018 Oct; 196(5):623-629. PubMed ID: 30099584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema.
    Huang HC; Chang HY; Chen CW; Lee CH; Hsiue TR
    Chest; 1999 Mar; 115(3):751-6. PubMed ID: 10084488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
    Uyan AP; Ozyürek H; Yilmaz E
    Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of post-pneumonic empyema thoracis.
    Athanassiadi K; Gerazounis M; Kalantzi N
    Thorac Cardiovasc Surg; 2003 Dec; 51(6):338-41. PubMed ID: 14669131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions.
    Chin NK; Lim TK
    Chest; 1997 Feb; 111(2):275-9. PubMed ID: 9041968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical management of parapneumonic pleural disease.
    Barnes NP; Hull J; Thomson AH
    Pediatr Pulmonol; 2005 Feb; 39(2):127-34. PubMed ID: 15573391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.